Fluarix Tetra

Fluarix Tetra is an influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A. in the EU.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. It is typically recommended for individuals seeking protection against seasonal flu strains. The vaccine is part of a broader effort to reduce the impact of influenza on public health.

Common effects of Fluarix Tetra may include soreness at the injection site, mild fever, and general discomfort. These effects are usually temporary and resolve on their own. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Fluarix Tetra should be handled with care and stored according to the manufacturer's guidelines. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of the components should exercise caution. Always consult a healthcare provider before administration.

Fluarix Tetra may interact with other medications or vaccines. It is advisable to inform a healthcare provider about all current medications before receiving the vaccine. Alcohol and certain immune-suppressing drugs may affect the vaccine's efficacy.